VXRT — Vaxart, Inc.

—
OTC · Health Care · Biotechnology · CIK 72444 ·
Last close
$0.35
Market Cap
$86.51M
52W High
$0.84
52W Low
$0.33
ADV30
289,565
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 27,185,000 — -13,172,000 -13,494,000 165,185,000 50,929,000 82,814,000
Mar 2026 39,227,000 — 5,173,000 5,179,000 180,055,000 50,746,000 85,938,000
Dec 2025 104,239,000 — 55,423,000 55,045,000 186,079,000 53,814,000 98,281,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$33,982,000
Investing CF
$-7,225,000
Financing CF
$4,061,000
CapEx
$-601,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.15
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-468,510,000
Inventory
—
Receivables
$46,992,000
ST Investments
$13,047,000
EBIT TTM
$41,205,000
Pretax Income TTM
$39,008,000
Interest Exp TTM
$2,197,000
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$181,271,008
EBITDA
$35,335,000
Free Cash Flow
$-36,566,248
Enterprise Value
$37,193,752
Total Cash
$65,544,000
Total Debt
$12,568,000
Shares Out
243,700,562
Trailing EPS
$0.17
Book Value
$0.27
ROE
62.4%
ROA
10.5%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 237,258,000 18,074,000 16,327,000 186,079,000 98,281,000 87,798,000 7,714,000
Dec 2024 28,700,000 -66,293,000 -66,948,000 166,389,000 107,464,000 58,925,000 -44,764,000
Dec 2023 7,379,000 -83,347,000 -82,465,000 91,830,000 34,025,000 57,805,000 -70,453,000
Dec 2022 107,000 -110,333,000 -107,758,000 153,847,000 43,250,000 110,597,000 -94,779,000

TTM Snapshot

Revenues TTM
$243,064,000
NetIncome TTM
$38,589,000
OpCashFlow TTM
—
Assets (Latest)
$165,185,000
Forward EPS
$-1.03

Peers — same industry

TickerNameMarket CapLastDaily %
OTLK Outlook Therapeutics, Inc. $87.79M $0.36 —
BDTX Black Diamond Therapeutics, Inc. $82.75M $1.44 —
VYGR Voyager Therapeutics, Inc. $94.59M $1.52 —
CLLS Cellectis S.A. $77.08M $1.06 —
ARMP Armata Pharmaceuticals, Inc. $98.93M $2.66 —

News headlines (Yahoo Finance, 1h cache)

Vaxart Q3 Earnings Call Highlights
2026-11-08 23:14 · Yahoo
Vaxart Inc (VXRT) (Q3 2026) Earnings Call Highlights: Cash Runway Into Q2 2027, COVID-19 ...
2026-11-07 05:17 · Yahoo
Vaxart, Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
VAXART, INC. (VXRT) Reports Q3 Loss, Beats Revenue Estimates
2026-11-06 00:00 · Yahoo
Vaxart Provides Business Update and Reports Third Quarter 2026 Financial Results
2026-11-05 21:05 · Yahoo
Vaxart to Host Stockholder Fireside Chat on November 6 at 4:30 p.m. ET
2026-10-29 12:00 · Yahoo
Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors
2026-10-19 12:00 · Yahoo
Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model
2026-10-08 12:40 · Yahoo
Vaxart Highlights Oral Vaccine Platform, COVID Trial Progress at H.C. Wainwright Conference
2026-09-15 06:02 · Yahoo
Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-08 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.